$3.84
0.041.05%
At close: -
$3.98
0.143.54%
After Hours: 5:06 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Revance Therapeutics in recent months.
Browse guidance and forecast on all stocks.